problemi i resheniya v bazisnoy terapii xobl

PDF 34 sahifa 1,6 MB Bepul yuklash

Sahifa ko'rinishi (5 sahifa)

Pastga aylantiring 👇
1 / 34
powerpoint presentation problemi i resheniya v bazisnoy terapii xobl /ult/ppt/04.18/0 tolko dlya meditsinskix i farmatsevticheskix rabotnikov. dlya rasprostraneniya v mestax provedeniya meditsinskix ili farmatsevticheskix vistavok, seminarov, konferentsiy i inix podobnix meropriyatiy. professor m.a. xaritonov, zamestitel glavnogo pulmonologa mo rf, professor1 kafedri terapii (usovershenstvovaniya vrachey) voenno-meditsinskoy akademii , d.m.n sankt-peterburg 21 maya 2018 opredelenie i rasprostranennost xobl v mire v sootvetstvii s dannimi vsemirnoy organizatsii zdravooxraneniya (voz) xobl srednetyajelogo i tyajelogo techeniya stradayut 65 millionov chelovek2. ejegodno ot xobl umiraet okolo 3 mln chelovek, chto sostavlyaet 5% vsex prichin smerti2. 1. global strategy for the diagnosis, management and prevention of copd, global initiative for chronic obstructive lung disease (gold) 2018. http://www.goldcopd.org/ 2. http://www.who.int/respiratory/copd/burden/en/ xronicheskaya obstruktivnaya bolezn legkix (xobl) – rasprostranennoe zabolevanie, kotoroe mojno predotvratit i lechit, xarakterizuyusheesya persistiruyushimi respiratornimi simptomami i ogranicheniem skorosti vozdushnogo potoka, kotoroe svyazano s bronxialnimi i/ili alveolyarnimi narusheniyami, obichno vizivaemimi znachitelnim vozdeystviem povrejdayushix chastits ili gazov1 landis …
2 / 34
jeloe techenie xobl sredi lits starshe 40 let -10,1±4,8%. buist a., mcburnie m., vollmer w. et al. international variation in the prevalence of copd (the bold study): a population-based prevalence study. lancet, 2007, 370, 741-750. chuchalin et al international journal of copd 2014:9 963–974 diagnostika xobl faktori riska razvitiya xobl. vneshnie: kurenie, vliyanie promishlennoy biologicheskoy i mineralnoy pili, ximicheskix veshestv, zagryaznenie okrujayushey sredi vnutrennie: geneticheskaya predraspolojennost, narushenie rosta legochnoy tkani, nalichie bronxialnoy reaktivnosti ili astmi v anamneze, tyajelie respiratornie infektsii, perenesennie v detskom vozraste. jalobi i anamnez. simptomi xobl:  kashel (suxoy ili produktivniy)  narastayushaya odishka pri fizicheskoy nagruzke ili v pokoe preimushestvenno razvitie bolezni v vozraste starshe 40 let, chastota obostreniy xobl (0-1 nechastie obostreniya ili ≥2 – chastie obostreniya) dannie spirometricheskogo issledovaniya ofv1/fjel posle probi s bronxolitikom menee 0,7 – kriteriy postanovki diagnoza xobl opredelenie stepeni tyajesti narusheniya bronxialnoy proxodimosti: ot legkoy do krayne tyajeloy (spirometricheskaya klassifikatsiya …
3 / 34
obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ otsenka simptomov xobl:  modifitsirovannaya shkala mmrc (modified medical research council dyspnea scale): stepen virajennosti odishki. simptomi (odishka) schitayutsya virajennimi, esli bolnoy po shkale mmrc nabiraet 2 i bolee ballov1.  test cat (copd assessment test): vliyanie xobl na povsednevnuyu jizn i samochuvstvie patsientov. vklyuchaet 8 voprosov, pri rezultate 10 i bolee ballov, sleduet schitat, chto u bolnogo virajennie simptomi2 1. bestall jc, paul ea, garrod r, garnham r, jones pw, wedzicha ja: usefulness of the medical research council (mrc) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. thorax 1999; 54: 581–586. 2. jones pw, harding g, berry p, wiklund i, chen wh, kline leidy n: development and first validation of the copd assessment test. eur respir j 2009; 34: 648–654.  srednetyajelie obostreniya xobl (trebuyushie naznacheniya kortikosteroidnoy i/ili antibakterialnoy terapii)  tyajelie obostreniya (trebuyushie gospitalizatsii) otsenka obostreniy xobl global strategy …
4 / 34
vki diagnoza xobl otsenka dannix spirometrii pri xobl: global strategy for the diagnosis, management and prevention of copd, global initiative for chronic obstructive lung disease (gold) 2018. http://www.goldcopd.org/ federalnie klinicheskie rekomendatsii po lecheniyu xobl, 2017 http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ bronxodilatatsionniy test (proba s bronxolitikom)  400 mkg salbutamola (β2-agonist) → povtornaya spirometriya cherez 15-30 minut  bronxodilatatsionniy test schitaetsya polojitelnim, esli posle ingalyatsii bronxodilatatora koeffitsient bronxodilatatsii (kbd) po ofv1 sostavlyaet ne menee 12%, i pri etom absolyutniy prirost sostavlyaet 200 ml i bolee http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ http://spulmo.ru/obrazovatelnye-resursy/federalnye-klinicheskie-rekomendatsii/ kdba kdaxp ddaxp ddba ddba+ ddaxp igks + ddba ifde 4 kak vibrat preparat dlya terapii xobl? igks – ingalyatsionnie glyukokortikosteroidi ddba – dlitelno deystvuyushie β2-agonisti ddaxp – dlitelno deystvuyushie antixolinergicheskie preparati kdba – korotko deystvuyushie β2-agonisti kdaxp – korotko deystvuyushie antixolinergicheskie preparati ifde-4 – ingibitori fosfodiesterazi-4 opredelenie gruppi po gold global strategy for the diagnosis, management and prevention of copd, global …
5 / 34
ti obostreniy (srednetyajelix i tyajelix) redkie simptomi, redkie obostreniya redkie simptomi, chastie obostreniya chastie simptomi, chastie obostreniya chastie simptomi, redkie obostreniya otsenit effekt prodoljayushiesya simptomi gruppa a bronxolitik prodoljit, prekratit ili naznachit bronxolitik drugogo klassa gruppa b ddaxp ili ddba ddaxp + ddba povt. obostr. gruppa c ddaxp ddaxp + ddba ddba+igks povt. obostreniya gruppa d ddaxp dobavit roflumilast* dobavit makrolidi** ddaxp + ddba ddba + igks ddaxp + ddbaa + igks prodolj. simptomi, povt. obostr.) povt. obostr. gold 2018: vibor bazisnoy terapii xobl predpochtitelnaya terapiya global strategy for the diagnosis, management and prevention of copd, global initiative for chronic obstructive lung disease (gold) 2018. available from: http://www.goldcopd.org igks – ingalyatsionnie glyukokortikosteroidi ddba – dlitelno deystvuyushie β2-agonisti ddaxp – dlitelno deystvuyushie antixolinergicheskie preparati kdba – korotko deystvuyushie β2-agonisti kdaxp – korotko deystvuyushie antixolinergicheskie preparati ifde-4 – ingibitori fosfodiesterazi-4 vsem patsientam xobl v kachestve bazisnoy terapii pokazani bronxolitiki dlitelnogo deystviya v …

Ko'proq o'qimoqchimisiz?

Barcha 34 sahifani Telegram orqali bepul yuklab oling.

To'liq faylni yuklab olish

"problemi i resheniya v bazisnoy terapii xobl" haqida

powerpoint presentation problemi i resheniya v bazisnoy terapii xobl /ult/ppt/04.18/0 tolko dlya meditsinskix i farmatsevticheskix rabotnikov. dlya rasprostraneniya v mestax provedeniya meditsinskix ili farmatsevticheskix vistavok, seminarov, konferentsiy i inix podobnix meropriyatiy. professor m.a. xaritonov, zamestitel glavnogo pulmonologa mo rf, professor1 kafedri terapii (usovershenstvovaniya vrachey) voenno-meditsinskoy akademii , d.m.n sankt-peterburg 21 maya 2018 opredelenie i rasprostranennost xobl v mire v sootvetstvii s dannimi vsemirnoy organizatsii zdravooxraneniya (voz) xobl srednetyajelogo i tyajelogo techeniya stradayut 65 millionov chelovek2. ejegodno ot xobl umiraet okolo 3 mln chelovek, chto sostavlyaet 5% vsex prichin smerti2. 1. global strategy for the diagnosis, manage...

Bu fayl PDF formatida 34 sahifadan iborat (1,6 MB). "problemi i resheniya v bazisnoy terapii xobl"ni yuklab olish uchun chap tomondagi Telegram tugmasini bosing.

Teglar: problemi i resheniya v bazisnoy… PDF 34 sahifa Bepul yuklash Telegram